DM
TRIV

Deerfield Management’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Deerfield Management’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-990,202
Closed -$10.4M – 146
2015
Q1 		$10.4M Sell
990,202
-158,373
-14% -$1.63M 0.34% 60
2014
Q4 		$14.4M Sell
1,148,575
-383,956
-25% -$5.24M 0.52% 49
2014
Q3 		$22.2M Buy
1,532,531
+49,865
+3% +$724K 0.81% 44
2014
Q2 		$23.1M Buy
+1,482,666
New +$22.5M 0.93% 38

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management's TRIV Position: Q2 2015 in Review

Deerfield Management sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 990,202 shares — an estimated $10.4M sold.

Deerfield Management first reported a position in TRIV in Q2 2014 and held it in 4 quarters. The position peaked at $23.1M in Q2 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.

  • Deerfield Management reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • Deerfield Management sold 990,202 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $10.4M.
  • Deerfield Management first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 4 quarters.
  • Deerfield Management's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $23.1M in Q2 2014.
  • 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.

Based on Deerfield Management's 13F filing for Q2 2015, filed 14 Aug 2015.